Trial ‘Desperately Needed’ to Sequence Immunotherapy and Chemo in Lung Cancer – Medscape
Medscape |
Trial 'Desperately Needed' to Sequence Immunotherapy and Chemo in Lung Cancer
Medscape Skeptics might argue that the study was not necessarily concurrent versus sequential, but rather 100% of people getting chemotherapy and immunotherapy versus 50% of patients getting chemotherapy and immunotherapy. We have this option available, and … |
